COMP <GO>
ABSI vs NRC // NET PROFIT MARGIN
Absci Corporation (NASDAQ) VS. NRC Health (NASDAQ) • 15-METRIC TALLY: ABSI 1
— NRC 5
■ METRIC PARITY
LAST: $12.10 (+1.85%) • MKT CAP: $2.08B
net-margins
—
LAST: $23.49 (+0.09%) • MKT CAP: $519.6M
net-margins
8.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ABSI VS. NRC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ABSI | NRC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 21.00% | -56.00 | NRC | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.6x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -4.53% | 3.03% | -7.56 | NRC | /fcf-yield <GO> |
| Operating Margin | — | 16.40% | — | TIE | /operating-margins <GO> |
| Net Profit Margin ACTIVE | — | 8.40% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -4.00% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.11% | -2.11 | NRC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.82 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 4/9 | -2.00 | NRC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.7 | 66.7 | -8.95 | NRC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 41.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.08B | $519.6M | $1.56B | ABSI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ABSI REV | NRC REV | ABSI GROSS % | NRC GROSS % | ABSI FCF | NRC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $137.4M | — | — | -$94.0M | $15.7M |
| FY 2024 | $4.5M | $143.1M | — | — | -$72.8M | $19.2M |
| FY 2023 | $5.7M | $148.6M | — | — | -$64.6M | $38.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ABSI // BETA —
NRC // BETA —